368 related articles for article (PubMed ID: 9238050)
1. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.
Brodsky RA; Vala MS; Barber JP; Medof ME; Jones RJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8756-60. PubMed ID: 9238050
[TBL] [Abstract][Full Text] [Related]
2. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.
Ware RE; Nishimura J; Moody MA; Smith C; Rosse WF; Howard TA
Blood; 1998 Oct; 92(7):2541-50. PubMed ID: 9746796
[TBL] [Abstract][Full Text] [Related]
3. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
4. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis.
Brodsky RA; Hu R
Leuk Lymphoma; 2006 Jul; 47(7):1215-21. PubMed ID: 16923549
[TBL] [Abstract][Full Text] [Related]
5. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
6. Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
Savage WJ; Barber JP; Mukhina GL; Hu R; Chen G; Matsui W; Thoburn C; Hess AD; Cheng L; Jones RJ; Brodsky RA
Exp Hematol; 2009 Jan; 37(1):42-51. PubMed ID: 19013003
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of paroxysmal nocturnal hemoglobinuria.
Parker CJ
Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
[TBL] [Abstract][Full Text] [Related]
8. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
Nishimura J; Murakami Y; Kinoshita T
Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
[TBL] [Abstract][Full Text] [Related]
10. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of paroxysmal nocturnal hemoglobinuria.
Rosti V
Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.
Kunyaboon R; Wanachiwanawin W; U-Pratya Y; Thedsawad A; Taka O
Hematol Oncol Stem Cell Ther; 2012; 5(3):138-45. PubMed ID: 23095789
[TBL] [Abstract][Full Text] [Related]
13. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
[TBL] [Abstract][Full Text] [Related]
14. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
Bessler M
Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
[TBL] [Abstract][Full Text] [Related]
15. New insights into paroxysmal nocturnal hemoglobinuria.
Brodsky RA
Hematology Am Soc Hematol Educ Program; 2006; ():24-8, 516. PubMed ID: 17124035
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
[TBL] [Abstract][Full Text] [Related]
17. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
[TBL] [Abstract][Full Text] [Related]
18. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
Shichishima T
Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
[TBL] [Abstract][Full Text] [Related]
19. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
[TBL] [Abstract][Full Text] [Related]
20. [Mutations in the PIG-A gene lead to GPI-deficiency in paroxysmal nocturnal hemoglobinuria].
Ostendorf T; Schubert J; Schmidt RE
Immun Infekt; 1994 Aug; 22(4):154-5. PubMed ID: 7927481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
